Financial Derivatives (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Derivatives [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Fair Value of Financial Derivatives | The fair value of the financial derivatives as of December 31, 2025 and March 31, 2026 were as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Derivative Instruments | The gain (loss) related to the Company’s derivative instruments for the three months period ended March 31, 2025 and 2026 were as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||